From post

Designed delays versus rigorous pragmatic trials: lower carat gold standards can produce relevant drug evaluations.

, , и . Medical care, 45 (10 Supl 2): S44-9 (октября 2007)6352<m:linebreak></m:linebreak>GR: AG19463/AG/NIA NIH HHS/United States; JID: 0230027; 0 (Cyclooxygenase 2 Inhibitors); ppublish;<m:linebreak></m:linebreak>CER.
DOI: 10.1097/MLR.0b013e318068932a

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed.

 

Другие публикации лиц с тем же именем

Adjustments for unmeasured confounders in pharmacoepidemiologic database studies using external information., , , , и . Medical care, 45 (10 Supl 2): S158-65 (октября 2007)6354<m:linebreak></m:linebreak>LR: 20091118; GR: R01 023178/PHS HHS/United States; GR: R01 AG023178-03/AG/NIA NIH HHS/United States; JID: 0230027; 0 (Anti-Inflammatory Agents, Non-Steroidal); RF: 46; NIHMS40822; OID: NLM: NIHMS40822; OID: NLM: PMC2265540; ppublish;<m:linebreak></m:linebreak>CER.Emulation of Randomized Clinical Trials With Nonrandomized Database Analyses, , , , , , , , , и 17 other автор(ы). 329 (16): 1376 (2023)Designed delays versus rigorous pragmatic trials: lower carat gold standards can produce relevant drug evaluations., , и . Medical care, 45 (10 Supl 2): S44-9 (октября 2007)6352<m:linebreak></m:linebreak>GR: AG19463/AG/NIA NIH HHS/United States; JID: 0230027; 0 (Cyclooxygenase 2 Inhibitors); ppublish;<m:linebreak></m:linebreak>CER.Instrumental variable methods in comparative safety and effectiveness research., , и . Pharmacoepidemiology and drug safety, 19 (6): 537-54 (июня 2010)5676<m:linebreak></m:linebreak>GR: 1 K01 HS018088/HS/AHRQ HHS/United States; GR: 290-2005-0016-I-TO3-WA1/PHS HHS/United States; GR: K25AG027400/AG/NIA NIH HHS/United States; JID: 9208369; NIHMS205457; OID: NLM: NIHMS205457 Available on 06/01/11; OID: NLM: PMC2886161 Available on 06/01/11; ppublish;<m:linebreak></m:linebreak>Variables instrumentals.Transparency in real-world evidence (RWE) studies to build confidence for decision-making: Reporting RWE research in diabetes., , и . Diabetes, obesity & metabolism, (апреля 2020)Databases; Diabetis; CER; Publicació; Checklist.One-to-many propensity score matching in cohort studies., , , , , и . Pharmacoepidemiology and drug safety, (мая 2012)Propensity score.High-dimensional propensity score adjustment in studies of treatment effects using health care claims data., , , , , и . Epidemiology (Cambridge, Mass.), 20 (4): 512-22 (июля 2009)5216<m:linebreak></m:linebreak>GR: R01-AG018833/AG/NIA NIH HHS/United States; GR: R01-AG021950/AG/NIA NIH HHS/United States; GR: R01-AG023178/AG/NIA NIH HHS/United States; GR: R01-AG027400/AG/NIA NIH HHS/United States; GR: R01-MH078708/MH/NIMH NIH HHS/United States; JID: 9009644; CIN: Epidemiology. 2009 Jul;20(4):523-4. PMID: 19525688; ppublish;<m:linebreak></m:linebreak>Propensity score.Reliable insights regarding medication outcomes from real world data- key principles of an evidence generation framework., , , , и . AMIA, AMIA, (2021)Evaluating short-term drug effects using a physician-specific prescribing preference as an instrumental variable., , , и . Epidemiology (Cambridge, Mass.), 17 (3): 268-75 (мая 2006)4043<m:linebreak></m:linebreak>Variables instrumentals.Understanding secondary databases: a commentary on "Sources of bias for health state characteristics in secondary databases".. Journal of clinical epidemiology, 60 (7): 648-50 (июля 2007)4789<br/>LR: 20071203; GR: 2 R01-HS010881/HS/AHRQ HHS/United States; GR: R01-AG023178/AG/NIA NIH HHS/United States; GR: R01-AG21950/AG/NIA NIH HHS/United States; JID: 8801383; CON: J Clin Epidemiol. 2007 Jul;60(7):734-41. PMID: 17573990; 2006/10/17 received; 2006/10/17 accepted; 2007/02/26 aheadofprint; ppublish;<br/>Databases.